A genome-wide association study among Europeans related polymorphisms of the TLR locus at 4p14 and the FCGR2A locus at 1q23.3 to Helicobacter pylori serologic status. We replicated associations of 4p14 but not 1q23.3 with anti-H. pylori antibodies in 1,402 Finnish males.
Introduction
Chronic Helicobacter pylori infection is causally associated with gastritis, gastroduodenal ulcer disease, gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. 1 A genome-wide association study (GWAS) of anti-H. pylori serologic status among Europeans identified inverse associations with single nucleotide polymorphism (SNPs) in the toll-like receptor (TLR) locus at 4p14 and the Fcγ receptor 2a (FCGR2A) locus at 1q23.3. 2 Comparing anti-H. pylori immunoglobulin G (IgG) antibody levels in the highest quartile vs. lower levels, the 4p14 associations were strongly significant (top-ranked SNP, rs10004195; P=1.4e-18) and the 1q23.3 associations were borderline (top-ranked SNP, rs368433; P=2.1e-8). In contrast, there were no genome-wide significant associations with anti-H. pylori antibody levels in a GWAS among Mexican-Americans. 3 To extend the previous findings among Caucasians, we evaluated associations of anti-H. pylori IgG with 4p14 and 1q23.3 loci in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (ATBC).
Results and discussion
Among ATBC participants, rs10004195-A at 4p14 was inversely associated with anti-H. pylori antibody levels in the highest 25%. The per-allele odds ratio (OR) was 0. Table 1 ).
We also found associations of 4p14 variants with continuous anti-H. pylori antibody levels.
Notably, the statistical significance as well as magnitude of effects was accentuated when we restricted our analysis to seropositive individuals ( Figure 1 Table 2 ). In analyses controlling for rs6835514, the effect of rs10004195 did not remain significant (beta=−0.03; SE=0.06; P=5.5e-1), indicating that the two SNP associations with IgG levels are not independent.
Furthermore, we explored putative functional effects of these 52 4p14 SNPs based on publically available data. Except for rs4833095 (Asn248Ser) and synonymous rs5743614 in TLR1, all other variants were located in intronic or non-coding regions. However, many of these remaining SNPs fall within proximal or distal regulatory elements (Supplementary Table 3 ). Using the Roadmap ChromHMM track, we found 7 promoter SNPs and 8 enhancer SNPs in CD19-positive primary blood cells. In ENCODE cell lines, 17 SNPs were mapped to DNaseI hypersensitive regions and 42 SNPs altered binding motifs of at least one transcription factor. GTEx expression quantitative trait loci (eQTL) data on whole-blood samples identified multiple SNPs significantly correlated (P<0.01) with mRNA transcript levels of TLR6/10 or FAM114A1 but not with TLR1 (Supplementary Table 3 ). The low IgG allele (G) of rs6835514 was inversely associated with mRNA levels of TLR6 (beta=−0.11; P=3.2e-3) and positively associated with FAM114A1 expression (beta=0.31; P=3.7e-5) ( Figure 2 ). Of particular interest, rs10034903, which was mapped to an active promoter of TLR10 as well as a transcription factor binding site, appeared to be a significant eQTL for both TLR10 and FAM114A1 ( Figure 2 ). Similar to rs6835514, the low IgG allele (G) of rs10034903 was associated with decreased mRNA expression of TLR10 (beta=−0.13; P=6.5e-3) and increased mRNA expression of FAM114A1 (beta=0.27; P=8.0e-4).
Although roles in pathogen recognition and innate immunity have been well established, 4 little is known about TLR1/6/10 with respect to H. pylori response. 5 , 6 In a recent report, heterodimeric TLR2/TLR10 was suggested to mediate H. pylori lipopolysaccharide recognition in activating the NF-kB signaling pathway. 7 Additionally, a growing number of studies suggest genetic polymorphisms in TLR genes are associated with infectious disease susceptibility 8 . For example, rs5743618 (Ser602Ile of TLR1; r 2 =0.80 among CEU) in high LD with rs6835514 (r 2 =0.80 among CEU) has been associated with susceptibility to tuberculosis 9 , Chlamydia trachomtis infection 10 and leprosy 11 ; while rs4833095 (Asn248Ser of TLR1; r 2 =0.85 with rs6835514 among CEU) has been associated with Atopobium vaginae infection 12 and placental malaria 13 .
Intriguingly, 4p14 has also been implicated as a susceptibility locus for IgE-mediated allergic sensitization and for hay fever-related asthma; minor alleles were associated with decreased levels of IgE 14 and decreased risk of asthma 15 in Caucasians, in parallel with our finding of an inverse association with anti-H. pylori antibody levels. However, three TLR SNPs included in the current report were inconsistently associated with active H. pylori infection determined by 13 C-urea breath test in a Chinese population. 16 Further studies are warranted of these genetic polymorphisms in relation to target gene regulation and disease consequences. Fine mapping studies are also needed to pinpoint the functionally relevant causal variants.
As for the borderline association reported for 1q23. Figure 1) . Based on our observed 0.06 MAF of rs368433, estimated power to detect the previously reported 0.73 OR at a 5% significance level was 71% among all individuals and 80% among seropositives.
In conclusion, we confirmed the association of the 4p14 locus with anti-H. pylori antibodies among Caucasians, and clarified the phenotype affected by these polymorphisms. Our findings suggest that the 4p14 locus may modulate intensity of host immune response rather than acquisition of H. pylori infection per se. The clinical significance of higher levels of antibody to H. pylori remains to be determined; conflicting associations with either increased 17 , 18 or decreased 19 , 20 gastric cancer risk have been reported. Antigen specificity of the 4p14 locus associations should also be examined in future studies. These findings await extension to other ethnic/racial groups with differences in exposure patterns, bacterial strain pathogenicity, host genetic characteristics and population burdens of H. pyloriassociated diseases.
Materials and methods
Our study included participants from the ATBC, a randomized, double-blind, placebocontrolled trial conducted 1985-1993 in 29,133 Finnish male smokers aged 50 to 69 years. 21 Participants completed questionnaires at enrollment and serum samples were collected and stored at −70°C for future analyses. The current study included 1,402 participants who had both genotyping and H. pylori serology data available.
Antibodies to H. pylori were measured by enzyme-linked immunosorbent 22 , 23 , 24 , 25 and multiplex bead-based assays 26 , 27 , as described previously. In order to combine measurements based on different technologies, we standardized levels using laboratoryspecific means and standard deviations. Detailed information about genotyping and quality control was published previously 28 , 29 . Briefly, a genome-wide scan was performed with Illumina HumanHap550/610 arrays. Imputation was performed using the hidden-Markov model algorithm implemented in MACH, based on HapMap CEU reference panel build 36, R22.
We defined candidate regions as ±200 kb from the previously reported top SNPs, 2 rs10004195 at 4p14 (chr4:38584724-38984724, Hg19) and rs368433 at 1q23.3 (chr1:161284210-161684210, Hg19). We additionally included SNPs located in flanking regions of rs6835514 (chr4:38694380-39094380, Hg19), the most significant 4p14 SNP in our linear regression analysis. After quality control, 1,380 SNPs at 4p14 and 1,127 SNPs at 1q23.3 were available from genotyping or imputed data. Average call rate for the genotyped SNPs was 1 and average quality score for imputed SNPs (Rsq) was 0.92.
To refine the phenotype affected by gene polymorphisms, we tested several definitions of H. pylori serologic status. First, we used the same definition as the previous report in
Caucasians, which compared individuals with IgG levels in the highest 25% to individuals in the other 75%. Second, to determine whether the loci are associated with H. pylori acquisition, we compared seropositives to seronegatives. Lastly, we analyzed IgG levels as a continuous variable. We assumed an additive genetic model with number of minor alleles as a predictor, using 10-year age groups and genotying principal components as covariables. We used logistic regression for dichotomous outcome variables and linear regression for the continuous outcome variable. Adjustment for multiple comparisons at 4p14 was performed by the false discovery rate (FDR) based on 1,380 SNPs, ignoring the high correlation among the tested SNPs. Analyses were conducted using SAS v9.3 (SAS Institute Inc., Cary, NC) and R v3.1.3. Statistical power was estimated with CaTS (http://csg.sph.umich.edu/abecasis/ CaTS/index.html).
We focused functional annotation on the 52 SNPs located in moderate to high (r 2 >0.6) LD with rs6835514. The UCSC Genome browser (http://genome.ucsc.edu) was used to confirm genomic regions and to screen NIH Epigenomics Roadmap (http:// www.roadmapepigenomics.org/) and ENCODE (http://genome.ucsc.edu/ENCODE/) tracks. HaploReg (http://www.broadinstitute.org/mammals/haploreg/haploreg.php) and RegulomeDB (http://regulomedb.org/) were also used to confirm SNP functions and to compile summary results.
To map promoter, enhancer, polycomb-repressed or heterochromatin regions, we used the chromatin state segmentation by Hidden Markov Model (ChromHMM) track from Roadmap reported for CD19 primary cells (presumably, circulating B-lymphocytes). DNase cluster assigned by DNase I hypersensitive assay results from 125 cell types, transcription factor binding sites defined by chromatin immunoprecipitation sequencing for 161 factors, and transcription levels determined by RNA-seq in GM12878 were tracked using ENCODE.
To identify putative target genes regulated by SNPs, we compiled eQTL results assessed in whole blood samples (n=168) from Genotype-Tissue Expression (http://www.gtexportal.org/ home/). Linear regression was conducted for the 52 SNPs on log and quantile normalized RNA-seq levels of four genes to which any of these SNPs were mapped, including TLR1 (ENSG00000174125.3), TRL6 (ENSG00000174130.8), TLR10 (ENSG00000174123.6), and FAM114A1 (ENSG00000197712.7). Covariables included three genotyping principle components, 15 peer factors and sex. Based on the number of genes tested, our Bonferronicorrected significance threshold was P=0.012 (0.05/4 genes).
Informed consents were obtaind from all participants. The study was approved by IRBs of the National Public Health Institute of Finland and the US National Cancer Institute.
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